Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People undergoing their first radiofrequency ablation procedure for a type of irregular heartbeat (ventricular tachycardia) caused by ischaemic heart disease (reduced blood flow to the heart)
- People who have an implanted defibrillator (ICD) with remote monitoring capability
- Women who could become pregnant must be using effective contraception until they leave the hospital
- People who have given written consent to participate freely and without pressure
- People who have health insurance or are covered by a health fund
Who may not be able to join:
- People who have had certain types of heart surgery in the past (such as bypass surgery, heart valve replacement, or other operations that may have caused scar tissue around the heart) that could make one part of the procedure unsafe
- People found to have a blood clot inside the left side of the heart during pre-procedure scans
- People taking blood-thinning medication that cannot be safely paused for the procedure
- People taking two types of blood-thinning tablet together, where it is not possible to temporarily reduce this to just one
- People with a history of inflammation of the sac surrounding the heart (pericarditis)
- People who have previously had radiotherapy to the chest area
- People for whom general anaesthesia is not safe
- People who are pregnant or breastfeeding
- People who have previously had a serious reaction to heparin, a blood-thinning medication used during the procedure (confirm with trial site)
- People who are under legal protection orders, have restricted legal capacity, are not free to make their own decisions, or are unable to give informed consent
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Raphaël MARTINS, MD, PhD, Rennes University Hospital
Phone: 299282517
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Survival free from ventricular arrhythmia recurrence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.